Keyword Connections

•  Barbara Murphy

•  Robbert Slebos

Resources

• No matching connections

Communities

• No matching connections

Publications

• Comprehensive genomic characterization of head and neck squamous cell carcinomas.
  Cancer Genome Atlas Network
  (2015) Nature 517: 576-82
• LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
  Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG
  (2007) Cancer Cell 12: 239-51
• Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
  Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS
  (2006) J Clin Oncol 24: 476-83
• Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
  Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR
  (2006) J Clin Oncol 24: 4170-6
• Head and trunk in zebrafish arise via coinhibition of BMP signaling by bozozok and chordino.
  Gonzalez EM, Fekany-Lee K, Carmany-Rampey A, Erter C, Topczewski J, Wright CV, Solnica-Krezel L
  (2000) Genes Dev 14: 3087-92
• Characterization of HPV and host genome interactions in primary head and neck cancers.
  Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, Protopopov A, Yang L, Seth S, Song X, Tang J, Ren X, Zhang J, Pantazi A, Santoso N, Xu AW, Mahadeshwar H, Wheeler DA, Haddad RI, Jung J, Ojesina AI, Issaeva N, Yarbrough WG, Hayes DN, Grandis JR, El-Naggar AK, Meyerson M, Park PJ, Chin L, Seidman JG, Hammerman PS, Kucherlapati R, Cancer Genome Atlas Network
  (2014) Proc Natl Acad Sci U S A 111: 15544-9
• A 20-nucleotide element in the intestinal fatty acid binding protein gene modulates its cell lineage-specific, differentiation-dependent, and cephalocaudal patterns of expression in transgenic mice.
  Simon TC, Roberts LJ, Gordon JI
  (1995) Proc Natl Acad Sci U S A 92: 8685-9
• Atypical motor and sensory cortex activation in attention-deficit/hyperactivity disorder: a functional magnetic resonance imaging study of simple sequential finger tapping.
  Mostofsky SH, Rimrodt SL, Schafer JG, Boyce A, Goldberg MC, Pekar JJ, Denckla MB
  (2006) Biol Psychiatry 59: 48-56
• Adjusting head circumference for covariates in autism: clinical correlates of a highly heritable continuous trait.
  Chaste P, Klei L, Sanders SJ, Murtha MT, Hus V, Lowe JK, Willsey AJ, Moreno-De-Luca D, Yu TW, Fombonne E, Geschwind D, Grice DE, Ledbetter DH, Lord C, Mane SM, Lese Martin C, Martin DM, Morrow EM, Walsh CA, Sutcliffe JS, State MW, Devlin B, Cook EH, Kim SJ
  (2013) Biol Psychiatry 74: 576-84
• Collision of chronic lymphocytic leukemia/small lymphocytic lymphoma and melanoma.
  Dueber JC, Coffin CM
  (2013) Blood 121: 4819
• Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors.
  Nees M, Homann N, Discher H, Andl T, Enders C, Herold-Mende C, Schuhmann A, Bosch FX
  (1993) Cancer Res 53: 4189-96
• Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
  Clark ES, Whigham AS, Yarbrough WG, Weaver AM
  (2007) Cancer Res 67: 4227-35
• Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
  Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG
  (2006) Cancer Res 66: 8210-8
• Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.
  Uddin MJ, Crews BC, Blobaum AL, Kingsley PJ, Gorden DL, McIntyre JO, Matrisian LM, Subbaramaiah K, Dannenberg AJ, Piston DW, Marnett LJ
  (2010) Cancer Res 70: 3618-27
• Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control.
  Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, Bosch FX
  (1998) Cancer Res 58: 5-13
• Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.
  Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, Netterville JL, Levy S, Yarbrough WG, Chung CH
  (2006) Clin Cancer Res 12: 701-9
• A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma.
  Galloway TJ, Wirth LJ, Colevas AD, Gilbert J, Bauman JE, Saba NF, Raben D, Mehra R, Ma AW, Atoyan R, Wang J, Burtness B, Jimeno A
  (2015) Clin Cancer Res 21: 1566-73
• Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.
  Gelbard A, Garnett CT, Abrams SI, Patel V, Gutkind JS, Palena C, Tsang KY, Schlom J, Hodge JW
  (2006) Clin Cancer Res 12: 1897-905
• A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.
  Gilbert J, Rudek MA, Higgins MJ, Zhao M, Bienvenu S, Tsottles N, Chaudhry MA, Wahl R, Forastiere A, Gillison M
  (2012) Clin Cancer Res 18: 1735-42
• Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
  Gubanova E, Brown B, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N
  (2012) Clin Cancer Res 18: 1257-67
• Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
  Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, Baumann J, Burkey B, Netterville J, Sinard R, Yarbrough WG, Cmelak AJ, Slebos RJ, Shyr Y, Parker J, Gilbert J, Murphy BA
  (2010) Ann Oncol 21: 864-870
• Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
  Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CM
  (2014) Oncogene 33: 702-12
• Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.
  Clark ES, Brown B, Whigham AS, Kochaishvili A, Yarbrough WG, Weaver AM
  (2009) Oncogene 28: 431-44
• Anthropometry and head and neck cancer:a pooled analysis of cohort data.
  Gaudet MM, Kitahara CM, Newton CC, Bernstein L, Reynolds P, Weiderpass E, Kreimer AR, Yang G, Adami HO, Alavanja MC, Beane Freeman LE, Boeing H, Buring J, Chaturvedi A, Chen Y, D'Aloisio AA, Freedman M, Gao YT, Gaziano JM, Giles GG, Håkansson N, Huang WY, Lee IM, Linet MS, MacInnis RJ, Park Y, Prizment A, Purdue MP, Riboli E, Robien K, Sandler DP, Schairer C, Sesso HD, Ou Shu X, White E, Wolk A, Xiang YB, Zelenuich-Jacquotte A, Zheng W, Patel AV, Hartge P, Berrington de González A, Gapstur SM
  (2015) Int J Epidemiol 44: 673-81
• Malignant vagotonia due to selective baroreflex failure.
  Jordan J, Shannon JR, Black BK, Costa F, Ertl AC, Furlan R, Biaggioni I, Robertson D
  (1997) Hypertension 30: 1072-7
• Impulsivity and the modular organization of resting-state neural networks.
  Davis FC, Knodt AR, Sporns O, Lahey BB, Zald DH, Brigidi BD, Hariri AR
  (2013) Cereb Cortex 23: 1444-52
• Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2.
  Siqueira AS, Pinto MP, Cruz MC, Smuczek B, Cruz KS, Barbuto JA, Hoshino D, Weaver AM, Freitas VM, Jaeger RG
  (2016) Oncotarget 7: 47904-47917
• Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer.
  Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C, Bartek J, Bosch FX
  (1997) Int J Cancer 74: 383-9
• Diet and other risk factors for cancer of the salivary glands:a population-based case-control study.
  Zheng W, Shu XO, Ji BT, Gao YT
  (1996) Int J Cancer 67: 194-8
• Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma.
  Frederick BA, Helfrich BA, Coldren CD, Zheng D, Chan D, Bunn PA, Raben D
  (2007) Mol Cancer Ther 6: 1683-91
• Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.
  Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA
  (2013) Cancer 119: 4268-76
• Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer.
  Gilbert J, Murphy B, Dietrich MS, Henry E, Jordan R, Counsell A, Wirth P, Yarbrough WG, Slebos RJ, Chung CH
  (2012) Cancer 118: 1007-13
• Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck.
  Gilbert J, Cmelak A, Shyr Y, Netterville J, Burkey BB, Sinard RJ, Yarbrough WG, Chung CH, Aulino JM, Murphy BA
  (2008) Cancer 113: 186-92
• Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.
  Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M, National Comprehensive Cancer Network
  (2013) J Natl Compr Canc Netw 11: 917-23
• Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.
  Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M, National Comprehensive Cancer Network
  (2014) J Natl Compr Canc Netw 12: 1454-87
• Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma.
  Slebos RJ, Li M, Vadivelu S, Burkey BB, Netterville JL, Sinard R, Gilbert J, Murphy B, Chung CH, Shyr Y, Yarbrough WG
  (2008) Br J Cancer 98: 619-26